Compass Pathways: Shares Look Cheap, Proving Psilocybin Case Won’t Be Easy (NASDAQ:CMPS)
Alexander_Volkov/iStock via Getty Images Investment Thesis Compass Pathways (NASDAQ:CMPS) is a UK-based biotech pioneering a new combination therapy for treatment resistant depression (“TRD”) that involves administration of the psychedelic drug psilocybin – named COMP360 – […]
